CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Genome Biologics has developed a drug discovery platform that significantly accelerates pre-clinical studies using advanced genomics and big data analytics. This technology reduces the time and cost of bringing drug candidates to human trials, facilitating the development of treatments for various diseases.
Genome Biologics’ novel drug discovery platform addresses the inefficiencies in pre-clinical studies with a unique combination of genomics, molecular science and big data analytics.
Using patented single cell transgenic technology, the platform can express 50 different genes in a single animal in 6-8 weeks.
This breakthrough approach reduces pre-clinical study time and costs by a factor of 10x, allowing pharmaceuticals companies to bring drug candidates to the stage of human trials in 3-6 months…
GENOME BIOLOGICS UG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
